Key result
Totally endoscopic aortic valve replacement demonstrated a 1.50% rate of major adverse cardiac and cerebrovascular events within 30 days and a 1.50% overall hospital mortality.
Why the study?
The authors aimed to describe a new approach for totally endoscopic aortic valve replacement.
Cohort (n=266)
A totally endoscopic approach for aortic valve replacement is feasible, demonstrating low hospital mortality and acceptable morbidity rates in a retrospective cohort.
Endoscopic AVR appears feasible in selected patients; leaves open the need for prospective trials before wider adoption.
OBJECTIVES: Our goal was to describe a new approach for totally endoscopic aortic valve replacement. METHODS: From October 2017 through December 2020, a total of 266 consecutive patients underwent totally endoscopic aortic valve replacement. Reoperations and combinations were excluded. RESULTS: A total of 266 patients with a median age of 72 (64, 79) years underwent totally endoscopic aortic valve replacement; of these, 250 (93.98%) patients were designated to undergo surgery because of aortic valve stenosis. The median follow-up index was 0.69 (0.30, 0.90). Major adverse cardiac and cerebrovascular events occurred in 4 (1.50%) patients within 30 days. Overall hospital mortality was 1.50%. Twenty additional deaths (7.52%) occurred during the 3-year follow-up period. An early thoracoscopic revision was needed in 7 patients due to signs of bleeding or cardiac tamponade. Fourteen patients required a permanent pacemaker implant. CONCLUSIONS: Retrospective analysis of our early experience with totally endoscopic aortic valve replacement in 266 consecutive patients demonstrated satisfactory results, with low mortality and acceptable morbidity rates.
No takes yet. Share an insight, caveat, or question.
Yılmaz et al. (2022) conducted a cohort in Aortic valve stenosis (n=266). Totally endoscopic aortic valve replacement was evaluated on Major adverse cardiac and cerebrovascular events within 30 days. Totally endoscopic aortic valve replacement demonstrated a 1.50% rate of major adverse cardiac and cerebrovascular events within 30 days and a 1.50% overall hospital mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: